Clinical Trial Update: Comparison of Chemotherapy and Immunotherapy in Neoadjuvant Therapy for TNBC

View source ↗

Summary

Clinical trial update on a study comparing chemotherapy versus immunotherapy as neoadjuvant therapy for triple-negative breast cancer, with recruitment not yet …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Triple-negative Breast Cancer

Snippet

Sponsor: The First Affiliated Hospital with Nanjing Medical University | Conditions: TNBC, Triple Negative Breast Cancer | Status: NOT_YET_RECRUITING